Clinical Pharmacokinetics of Docetaxel
- 1 January 1999
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 36 (2), 99-114
- https://doi.org/10.2165/00003088-199936020-00002
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Phase I study on docetaxel and ifosfamide in patients with advanced solid tumoursBritish Journal of Cancer, 1998
- Sensitive determination of docetaxel in human plasma by liquid–liquid extraction and reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- Plasma concentrations of polysorbate 80 measured in patients following administration of docetaxel or etoposideCancer Chemotherapy and Pharmacology, 1997
- Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80Cancer Chemotherapy and Pharmacology, 1996
- Metabolism of docetaxel by human cytochromes P450: interactions with paclitaxel and other antineoplastic drugs.1996
- Docetaxel (Taxotere®) a review of preclinical and clinical experience. Part IAnti-Cancer Drugs, 1995
- Preclinical evaluation of docetaxel (Taxotere).1995
- Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimationCancer Chemotherapy and Pharmacology, 1995
- Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayersBiochemical Pharmacology, 1994
- Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic methodJournal of Chromatography B: Biomedical Sciences and Applications, 1992